Guided Imagery of the Gynecological Cancer
ConditionGynecologic Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-90
SponsorBaskent University
About this trial
The goal of this randomized controlled trial is to evaluate the effectiveness of a guided imagery intervention in women receiving chemotherapy for gynecological cancers at Başkent University Ankara Hospital Outpatient Chemotherapy Unit.
The main questions it aims to answer are:
Does guided imagery improve psychological or physical outcomes during chemotherapy? How do outcomes differ between the intervention (guided imagery) and control (standard information) groups?
Researchers will compare both groups to assess the effect of guided imagery across three repeated measurements.
Participants will:
* Be randomly assigned (1:1) to intervention or control groups via an online randomization tool. * Complete outcome assessments at three time points. * Be part of a sample of 158 women (minimum 76 per group), based on power analysis for repeated measures ANOVA (effect size f = 0.25, 95% power, 95% confidence).
The study will follow the CONSORT-Outcomes 2022 guideline and be registered at ClinicalTrials.gov.
Eligibility criteria
Qualifiers
Having a diagnosis of another type of cancer
An ECOG (Eastern Cooperative Oncology Group) performance score of ≥3 (PS 3: Confined to bed for more than half of the day, limited self-care; PS 4: Completely bedridden, unable to perform self-care)
Disqualifiers
Choosing to withdraw from the study
Refusing to practice guided imagery before chemotherapy treatment
Trial design
Treatments tested in this trial
- guided imagery
Treatment groups
46 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov